Diabetes Type 1: Clinical Trials

4 trials for Diabetes Type 1, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting. 4 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Completed 3, Recruiting 1
Phase 21Completed 1

Follow Diabetes Type 1: new trials by email Literature Review of Diabetes Type 1 trials Research Report on Diabetes Type 1

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Trial to Evaluate The Effects of Semaglutide and Empagliflozin Combined to Automated Insulin Delivery on Diabetes Control in Adults Living With Type 1 Diabetes
Intervention Period 1: Semaglutide + Empagliflozin, Intervention Period 2: Semaglutide + Empagliflozin Placebo, Intervention Period 3: Semaglutide Placebo + Empagliflozin - Diabetes Type 1
Phase 3RecruitingMcGill University Health Centre/Research Institute of the McGill University Health Centre362025-04-012025-03-30
A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes
LY900014, Insulin lispro - Diabetes Type 1
Phase 3CompletedEli Lilly and Company492018-02-212019-10-08
Comparison of Insulin's Injection Before or After the Meal in Type 1 Diabetic Patients Treated With Insulin Pump
Insulin Aspart - Diabetes Type 1
Phase 3CompletedUniversity Hospital, Brest222015-09-012025-12-03
Home and School Visits Intervention for Children With DM TYPE 1
Home and school visits - Diabetes Type 1
Phase 2 / Phase 3CompletedBen-Gurion University of the Negev922012-01-012014-05-13

Narrower conditions

Diabetes Mellitus, Type 1 (4)  ·  Insulin Resistance (1)

Broader conditions

Autoimmune Diseases (4)  ·  Diabetes Mellitus (4)  ·  Endocrine System Diseases (4)  ·  Glucose Metabolism Disorders (4)  ·  Immune System Diseases (4)  ·  Metabolic Diseases (4)  ·  Nutritional and Metabolic Diseases (4)  ·  Hyperinsulinism (1)

Interventions

Home Care Services (1)  ·  Insulin Aspart (1)  ·  Insulin Lispro (1)  ·  NOP-bolus regimen (1)  ·  empagliflozin (1)

Sponsors

Ben-Gurion University of the Negev (1)  ·  Eli Lilly and Company (1)  ·  McGill University Health Centre/Research Institute of the McGill University Health Centre (1)  ·  University Hospital, Brest (1)

Countries

Canada (1)  ·  France (1)  ·  Israel (1)  ·  Spain (1)  ·  United States (1)

Top investigators

Dr. Ahmad Haidar (1)  ·  Dr. Melissa-Rosina Pasqua (1)  ·  Dr. Michael Tsoukas (1)  ·  Dr. Vanessa Tardio (1)

Results publications

PMID 29749032

NIH funding

2015 (1), 2017 (1), 2025 (1)